Dose-response: Exercise Therapy on Hip Osteoarthritis

Dose-response: Exercise Therapy on Hip Osteoarthritis, a Pilot Study

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01700933

Enrollment

Registered

2012-10-04

Start date

2012-09-30

Completion date

2014-12-31

Last updated

2017-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Hip

Keywords

Exercise therapy

Brief summary

Osteoarthritis is a common disease that causes muscle weakness, stiffness and instability. The disease reduces the opportunities for an active lifestyle. Exercise Therapy provides a well-documented effect on pain and function in patients with osteoarthritis of the hip. It is sought an optimal dose of exercise, in which this study will help to investigate. We hypothesize that an exercise program designed to have a high number of repetitions will benefit the outcome of the training in a more positive way than a low-repetition based program.

Interventions

OTHERHigh-Dosage Exercise Therapy

Structure of the exercise program done three times per week, for eight weeks: 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 30 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 30 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.)

OTHERLow-Dosage Exercise Therapy

Structure of the exercise program done three times per week, for eight weeks: 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 10 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.) Four local exercises (3 series of 10 repetitions) 5-10 minutes of global exercise (cycling, walking on treadmill etc.)

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

45 Years to No maximum

Healthy volunteers

Inclusion criteria

* At least three month since debut of the disease * Age above 45 years * Ability to complete the intervention

Exclusion criteria

* Pain above 4 on VAS during gait * Pregnancy * Autoimmune disease * Cardiovascular disease * Respiratory disease * Metabolic disease * Neurological signs * Planned hip-replacement surgery within the next year * Received exercise therapy within the last 3 months

Design outcomes

Primary

Measure	Time frame	Description
WOMAC Index of Osteoarthritis (questionnaire)	0 weeks, 8 weeks, 6 months postinterventional	WOMAC Index of Osteoarthritis (questionnaire)

Secondary

Measure	Time frame	Description
HAD questionnaire	0 weeks, 8 weeks, 6 months postinterventional	—
Tampa Scale for Kinesiophobia	0 weeks, 8 weeks, 6 months postinterventional	—
Squats	0 weeks, 8 weeks, 6 months postinterventional	Number of squats completed in 30 seconds.
Stairs	0 weeks, 8 weeks, 6 months postinterventional	Time used to walk up and down 12 steps.

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026